Fenoterol hydrobromide steroid

Data from a large, placebo-controlled US study that compared the safety of another long-acting beta2-adrenergic agonist (salmeterol) with placebo added to usual asthma therapy showed an increase in asthma-related deaths in patients receiving salmeterol. This finding with salmeterol is considered a class effect of all LABA, including olodaterol, one of the active ingredients in STIOLTO RESPIMAT. The safety and efficacy of STIOLTO RESPIMAT in patients with asthma have not been established. STIOLTO RESPIMAT is not indicated for the treatment of asthma.

Fenoterol hydrobromide steroid

fenoterol hydrobromide steroid

Media:

fenoterol hydrobromide steroidfenoterol hydrobromide steroidfenoterol hydrobromide steroidfenoterol hydrobromide steroidfenoterol hydrobromide steroid

http://buy-steroids.org